Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
39.59
+0.38 (0.97%)
At close: Apr 28, 2026, 4:00 PM EDT
39.98
+0.39 (0.99%)
After-hours: Apr 28, 2026, 5:06 PM EDT
Sionna Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Sionna Therapeutics stock have an average target of 50.13, with a low estimate of 24 and a high estimate of 63. The average target predicts an increase of 26.62% from the current stock price of 39.59.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Sionna Therapeutics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 5 |
| Buy | 0 | 1 | 1 | 2 | 2 | 2 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 8 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy Maintains $52 → $63 | Strong Buy | Maintains | $52 → $63 | +59.13% | Apr 28, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $58 | Strong Buy | Reiterates | $58 | +46.50% | Apr 27, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $45 → $50 | Strong Buy | Maintains | $45 → $50 | +26.29% | Mar 3, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $58 | Strong Buy | Reiterates | $58 | +46.50% | Mar 2, 2026 |
| Citizens | Citizens | Buy Initiates $63 | Buy | Initiates | $63 | +59.13% | Feb 24, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
3.83M
EPS This Year
-2.38
from -1.88
EPS Next Year
-2.65
from -2.38
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | 31.5M | ||||||
| Avg | n/a | 3.8M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.77 | -1.64 | ||||||
| Avg | -2.38 | -2.65 | ||||||
| Low | -3.16 | -3.80 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.